Gary’s qualifications include(1) Solicitor admitted to practice - High Court of Australia, Federal Court of Australia & WA Supreme Court(2) Registered Australian Patent & Trade Mark Attorney (3) Registered New Zealand Patent Attorney Gary’s Technology Speciality Areas: Biotechnology (inc. Molecular biology, genomics, microbiology, immunology & antibody technology, proteomics, nanotechnology, bioinformatics, plant & agri-biotech, food sciences); Pharmaceuticals; Medical Technologies & Diagnostics. Gary’s IP Specialty Areas: • IP protection in the Life Science and pharmaceuticals fields with extensive experience in strategic IP development, drafting, prosecution of patent applications & provides validity /FTO opinions.• contentious matters including patent oppositions and revocations, in Australia and New Zealand. A select number of matters that Gary has been leading Attorney & or Solicitor include: (a) Kirin Amgen’s defence of its Erythropoietin patent in Australia; (b) Murex Diagnostics HCV challenge in Australia, (settlement for Murex); (c) Human Genome Sciences oppositions associated with VEGF-C & DR5; (d) Amgen’s G-CSF, Leptin and anti-TNF Oppositions in Australia (e) Eli Lilly’s successful revocation of Pfizer’s Viagra patent(f) Eli Lilly’s defence of its Olanzapine (Zyprexa) patent(f) Eli Lilly’s defence of its raloxifene (Evista) patent (g) Danisco’s suit of Novozymes for its patent for methods of preparing bread,(f) Amgen’s defence of its PegFilgrastim patent(g) Eli Lilly’s successful defence of its Tadalafil (Cialis) patents